Clinical practice guidelines for the care and treatment of breast cancer: 9. Follow-up after treatment for breast cancer (2005 update)

Dr. Grunfeld is Professor of Medicine, Dalhousie University, and Director of Health Services and Outcomes Research, Cancer Care Nova Scotia, Halifax, NS. Dr. DhesyThind is with the Cancer Care Ontario Juravinski Regional Cancer Centre and is Assistant Professor in the Department of Medicine, McMaster University, Hamilton, Ont. Dr. Levine is Professor in the Departments of Clinical Epidemiology and Biostatistics and of Medicine and is the Buffet Taylor Chair in Breast Cancer Research, McMaster University, Hamilton, Ont.

[1]  T. Dimpfl,et al.  Quality of Life Influenced by Primary Surgical Treatment for Stage I-III Breast Cancer—Long-Term Follow-Up of a Matched-Pair Analysis , 2001, Annals of Surgical Oncology.

[2]  David C. Smith,et al.  Psychological support for patients undergoing breast cancer surgery: a randomised study , 1996, BMJ.

[3]  G. Hortobagyi,et al.  Pilot study of bone mineral density in breast cancer patients treated with adjuvant chemotherapy. , 1998, Cancer investigation.

[4]  M. L. Wood,et al.  Who provides follow-up care for patients with early breast cancer? , 1995, Canadian family physician Medecin de famille canadien.

[5]  N. Urban,et al.  A minimalist policy for breast cancer surveillance. , 1991, JAMA.

[6]  J. Bernhard,et al.  Adjuvant breast cancer treatment and cognitive function: current knowledge and research directions. , 2003, Journal of the National Cancer Institute.

[7]  P. Ganz,et al.  Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. , 2002, Journal of the National Cancer Institute.

[8]  J. Costantino,et al.  Tamoxifen and depression: more evidence from the National Surgical Adjuvant Breast and Bowel Project's Breast Cancer Prevention (P-1) Randomized Study. , 2001, Journal of the National Cancer Institute.

[9]  G. Lyman,et al.  Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  P. Goodwin,et al.  Adjuvant treatment and onset of menopause predict weight gain after breast cancer diagnosis. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  A. Paradiso,et al.  A survey in Puglia: the attitudes and opinions of specialists, general physicians and patients on follow-up practice. G.S.Bio.Ca.M. , 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

[12]  R. Barakat,et al.  Effect of adjuvant tamoxifen on the endometrium in women with breast cancer: a prospective study using office endometrial biopsy. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  F. Schuetz,et al.  Adjuvant clodronate treatment improves the overall survival of primary breast cancer patients with micrometastases to bone marrow - a longtime follow-up. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  G. Lyman,et al.  Weight gain associated with adjuvant tamoxifen therapy in stage I and II breast cancer: fact or artifact? , 1997, Breast Cancer Research and Treatment.

[15]  D. Cook,et al.  Rules of evidence and clinical recommendations on the use of antithrombotic agents. , 1992, Chest.

[16]  T. Powles,et al.  Oral clodronate for adjuvant treatment of operable breast cancer: Results of a randomized, double-blind, placebo-controlled multicenter trial , 2004 .

[17]  M. Muller,et al.  Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma , 1999, Cancer.

[18]  J. Cauley,et al.  American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  P. Lønning,et al.  Cognitive ability in childhood and cognitive decline in mid-life: longitudinal birth cohort study , 2003, BMJ : British Medical Journal.

[20]  N. Baxter.  Preventive health care, 2001 update: should women be routinely taught breast self-examination to screen for breast cancer? , 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[21]  L. Holmberg,et al.  HABITS (hormonal replacement therapy after breast cancer—is it safe?), a randomised comparison: trial stopped , 2004, The Lancet.

[22]  A. Liberati,et al.  Follow-up strategies for women treated for early breast cancer. , 2000, The Cochrane database of systematic reviews.

[23]  R. Prescott,et al.  Randomised comparison of 5 years of adjuvant tamoxifen with continuous therapy for operable breast cancer. The Scottish Cancer Trials Breast Group. , 1996, British Journal of Cancer.

[24]  N. Wilking,et al.  Influence of prior and subsequent pregnancy on breast cancer prognosis. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  S. Ziebland,et al.  Patients' views of routine hospital follow‐up: a qualitative study of women with breast cancer in remission , 1998, Psycho-oncology.

[26]  S. Payne,et al.  Patient initiated follow up of breast cancer , 2002, Psycho-oncology.

[27]  T. Nakano,et al.  Factors correlated with fatigue in disease-free breast cancer patients: application of the Cancer Fatigue Scale , 2000, Supportive Care in Cancer.

[28]  L. Philpotts,et al.  Screening for breast cancer. , 2003, Seminars in roentgenology.

[29]  D V Schapira,et al.  American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  Patricia A. Ganz,et al.  Breast cancer survivors: Psychosocial concerns and quality of life , 2005, Breast Cancer Research and Treatment.

[31]  P. Delmas,et al.  Bisphosphonate risedronate prevents bone loss in women with artificial menopause due to chemotherapy of breast cancer: a double-blind, placebo-controlled study. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  K. Pritchard,et al.  Clinical practice guidelines for the care and treatment of breast cancer: 14. The role of hormone replacement therapy in women with a previous diagnosis of breast cancer. , 2002, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[33]  A. M. Lindsey,et al.  Bone Mineral Density in Postmenopausal Breast Cancer Survivors , 2001, Journal of the American Academy of Nurse Practitioners.

[34]  W. Thompson,et al.  Epidemiology of contralateral breast cancer. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[35]  P. Sjödén,et al.  Effect of endocrine treatment on sexuality in premenopausal breast cancer patients: a prospective randomized study. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  D. Felsenberg,et al.  Multinational, Placebo-Controlled, Randomized Trial of the Effects of Alendronate on Bone Density and Fracture Risk in Postmenopausal Women with Low Bone Mass: Results of the FOSIT Study , 1999, Osteoporosis International.

[37]  M. Simon,et al.  Childbearing and survival after breast carcinoma in young women , 2003, Cancer.

[38]  P. Ganz,et al.  Sexuality following breast cancer. , 1999, Journal of sex & marital therapy.

[39]  J. Brisson,et al.  Type of mastectomy and quality of life for long term breast carcinoma survivors , 1998, Cancer.

[40]  H. Johansson,et al.  Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group. , 1995, Journal of the National Cancer Institute.

[41]  R. Chlebowski.  Obesity and early-stage breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  M Baum,et al.  Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer , 2005, The Lancet.

[43]  A. Moyer,et al.  Psychosocial outcomes of breast-conserving surgery versus mastectomy: a meta-analytic review. , 1997, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[44]  D. Cella,et al.  Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[45]  J. Hendriks,et al.  The contribution of routine follow‐up mammography to an early detection of asynchronous contralateral breast cancer , 1991, Cancer.

[46]  M Abdolell,et al.  Cognitive function in breast cancer patients receiving adjuvant chemotherapy. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[47]  C. Rock,et al.  Factors associated with weight gain in women after diagnosis of breast cancer. Women's Healthy Eating and Living Study Group. , 1999, Journal of the American Dietetic Association.

[48]  R. Sankila,et al.  Survival of breast cancer patients after subsequent term pregnancy: "healthy mother effect". , 1994, American journal of obstetrics and gynecology.

[49]  S. Orel,et al.  Breast cancer recurrence after lumpectomy and irradiation: role of mammography in detection. , 1992, Radiology.

[50]  A. Purushotham,et al.  Pregnancy after breast cancer. , 2003, European journal of cancer.

[51]  S. Singletary,et al.  Prophylactic mastectomy. , 2000, Journal of the American College of Surgeons.

[52]  S. Dibble,et al.  Differences in fatigue by treatment methods in women with breast cancer. , 1998, Oncology nursing forum.

[53]  W. Rakowski,et al.  Breast cancer in older women: quality of life and psychosocial adjustment in the 15 months after diagnosis. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[54]  T. Powles,et al.  Oral clodronate for adjuvant treatment of operable breast cancer: Results of a randomized, double-blind, placebo-controlled multicenter trial. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[55]  A. Verbeek,et al.  Routine follow-up examinations in breast cancer patients have minimal impact on life expectancy: a simulation study. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[56]  P. Ganz,et al.  Role of breast reconstructive surgery in physical and emotional outcomes among breast cancer survivors. , 2000, Journal of the National Cancer Institute.

[57]  A. Keramopoulos,et al.  Pregnancy and offspring after the appearance of breast cancer , 1996 .

[58]  T. Wobbes,et al.  Periodic follow-up after breast cancer and the effect on survival. , 2001, The European journal of surgery = Acta chirurgica.

[59]  L. Tabár,et al.  Screening for breast cancer. , 2005, Surgical oncology clinics of North America.

[60]  T. Powles,et al.  Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[61]  Claude Bouchard,et al.  Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: Executive summary , 1998 .

[62]  J. Brisson,et al.  Dietary change after breast cancer: extent, predictors, and relation with psychological distress. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[63]  C. Loprinzi.  It is now the age to define the appropriate follow-up of primary breast cancer patients. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[64]  M. Carcangiu.  Re: Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. , 1994, Journal of the National Cancer Institute.

[65]  E. Winer,et al.  Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[66]  T. O'Connell,et al.  Breast cancer and pregnancy. , 1985, Archives of surgery.

[67]  Christine Maguth Nezu,et al.  A problem‐solving approach to stress reduction among younger women with breast carcinoma , 2002, Cancer.

[68]  A. V. D. Van Der Zee,et al.  Tamoxifen effects on subjective and psychosexual well-being, in a randomised breast cancer study comparing high-dose and standard-dose chemotherapy , 2002, British Journal of Cancer.

[69]  P. Ganz,et al.  Life after breast cancer: understanding women's health-related quality of life and sexual functioning. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[70]  T. Powles,et al.  Randomized, placebo-controlled trial of clodronate in patients with primary operable breast cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[71]  H. Kraemer,et al.  EFFECT OF PSYCHOSOCIAL TREATMENT ON SURVIVAL OF PATIENTS WITH METASTATIC BREAST CANCER , 1989, The Lancet.

[72]  G. Hortobagyi,et al.  Pregnancy and offspring after adjuvant chemotherapy in breast cancer patients , 1990, Cancer.

[73]  J. Baty,et al.  Effect of tamoxifen on sexual functioning in patients with breast cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[74]  C. Redmond,et al.  Significance of ipsilateral breast tumour recurrence after lumpectomy , 1991, The Lancet.

[75]  M. Churn,et al.  Outpatient follow-up after treatment for early breast cancer: updated results after 5 years. , 2001, Clinical oncology (Royal College of Radiologists (Great Britain)).

[76]  M. O'neill,et al.  Overall survival from breast cancer in women pregnant or lactating at or after diagnosis , 1996, International journal of cancer.

[77]  C. Rock,et al.  A randomized trial of the effect of a plant-based dietary pattern on additional breast cancer events and survival: the Women's Healthy Eating and Living (WHEL) Study. , 2002, Controlled clinical trials.

[78]  B Fisher,et al.  Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors. , 1996, Journal of the National Cancer Institute.

[79]  R. Sanders,et al.  The value of symptom directed evaluation in the surveillance for recurrence of carcinoma of the breast. , 1991, Surgery, gynecology & obstetrics.

[80]  I. Ariel,et al.  The prognosis of patients who become pregnant after mastectomy for breast cancer. , 1989, International surgery.

[81]  B. Rosner,et al.  Weight, weight gain, and survival after breast cancer diagnosis. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[82]  C. Redmond,et al.  Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. , 1994, Journal of the National Cancer Institute.

[83]  C. Blomqvist,et al.  Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomized study in premenopausal breast cancer patients. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[84]  C. Blomqvist,et al.  Adjuvant clodronate treatment does not reduce the frequency of skeletal metastases in node-positive breast cancer patients: 5-year results of a randomized controlled trial. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[85]  T. Powles,et al.  Oral clodronate and reduction in loss of bone mineral density in women with operable primary breast cancer. , 1998, Journal of the National Cancer Institute.

[86]  Robert J Cersosimo,et al.  Tamoxifen for Prevention of Breast Cancer , 2003 .

[87]  E. Perez,et al.  A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer , 2003 .

[88]  M. Baum.  Anastozole (A) is superior to tamoxifen (T) in treatment of postmenopausal (PM) women with early breast cancer (EBC) - First results of the ATAC (Arimidex, tamoxifen, alone or in combination) trial (on behalf of the ATAC Trialists' Group) , 2002 .

[89]  Umberto Veronesi,et al.  Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. , 2002, The New England journal of medicine.

[90]  T. Reimer,et al.  Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[91]  D. Mant,et al.  Routine follow up of breast cancer in primary care: randomised trial , 1996, BMJ.

[92]  R. Cody,et al.  Subtle Differences in Quality of Life After Breast Cancer Surgery , 1999, Annals of Surgical Oncology.

[93]  R. Epstein,et al.  Popularity of less frequent follow up for breast cancer in randomised study: initial findings from the hotline study , 1997, BMJ.

[94]  S. Rodenhuis,et al.  Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. , 1998, Journal of the National Cancer Institute.

[95]  S. Ciatto,et al.  Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. National Research Council Project on Breast Cancer follow-up. , 1994, JAMA.

[96]  S. Self,et al.  Pregnancy after breast carcinoma , 1999, Cancer.

[97]  L. Fallowfield.  Psychosocial interventions in cancer , 1995, BMJ.

[98]  A. Recht,et al.  Mammographic detection of recurrent cancer in the irradiated breast. , 1987, AJR. American journal of roentgenology.

[99]  H. Chochinov,et al.  The effect of group psychosocial support on survival in metastatic breast cancer. , 2001, The New England journal of medicine.

[100]  R. Elashoff,et al.  Adjuvant dietary fat intake reduction in postmenopausal breast cancer patient management , 1991, Breast Cancer Research and Treatment.

[101]  D. Stewart,et al.  Long‐term breast cancer survivors: confidentiality, disclosure, effects on work and insurance , 2001, Psycho-oncology.

[102]  R. Gelber,et al.  Effect of pregnancy on overall survival after the diagnosis of early-stage breast cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[103]  G. Bleijenberg,et al.  Determinants of chronic fatigue in disease-free breast cancer patients: a cross-sectional study. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[104]  A. McTiernan,et al.  Weight loss in breast cancer patient management. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[105]  C. Blomqvist,et al.  Ten-year follow-up of a randomized controlled trial of adjuvant clodronate treatment in node-positive breast cancer patients , 2004, Acta oncologica.

[106]  P. Ganz,et al.  Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[107]  R. Chlebowski,et al.  The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants. , 2003, Annals of epidemiology.

[108]  Tamoxifen for prevention of breast cancer. , 1999, The Medical letter on drugs and therapeutics.

[109]  J. Dewar.  Follow up in breast cancer , 1995, BMJ.

[110]  E. Tan-chiu,et al.  Zoledronic acid (ZA) effectively inhibits cancer treatment-induced bone loss (CTIBL) in postmenopausal women (PMW) with early breast cancer (BCa) receiving adjuvant letrozole (Let): 12 mos BMD results of the Z-FAST trial , 2005 .

[111]  Andrew J Saykin,et al.  Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[112]  M. Indelli,et al.  Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. The GIVIO Investigators. , 1994, JAMA.

[113]  P. Ganz,et al.  Predictors of sexual health in women after a breast cancer diagnosis. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[114]  M. Levine,et al.  Raloxifene: handle with care. , 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[115]  Y. Uchitomi,et al.  The effect of a psychosocial group intervention on loneliness and social support for Japanese women with primary breast cancer. , 2003, Oncology nursing forum.

[116]  E. Mamounas,et al.  Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer. , 2003, Journal of the National Cancer Institute.

[117]  P. Ganz,et al.  Breast cancer in younger women: reproductive and late health effects of treatment. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[118]  M. Jones,et al.  Carcinoma of the breast associated with pregnancy , 1986, The British journal of surgery.

[119]  T. Spector,et al.  A high incidence of vertebral fracture in women with breast cancer , 1999, British Journal of Cancer.

[120]  I. Olivotto,et al.  Early breast cancer: detection of recurrence after conservative surgery and radiation therapy. , 1990, Radiology.

[121]  D. Coyle,et al.  Surveillance mammography after treatment of primary breast cancer: a systematic review. , 2002, Breast.

[122]  I. Tannock,et al.  Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[123]  W. Mysiw,et al.  Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. , 1990, The New England journal of medicine.

[124]  D. Mant,et al.  Evaluating primary care follow-up of breast cancer: methods and preliminary results of three studies. , 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

[125]  T. Hurley,et al.  Efficacy of Therapeutic Group by Telephone for Women With Breast Cancer , 2003, Cancer nursing.

[126]  M. Espié,et al.  Long-term quality of life in premenopausal women with node-negative localized breast cancer treated with or without adjuvant chemotherapy , 2000, British Journal of Cancer.

[127]  H. Genant,et al.  Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. , 1990, The New England journal of medicine.

[128]  J. Cuzick,et al.  Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial , 2002, The Lancet.

[129]  R. Foster,et al.  Breast self-examination practices and breast cancer survival , 1985 .

[130]  Jong-Hyeon Jeong,et al.  Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. , 2002, The New England journal of medicine.

[131]  S. Cummings,et al.  Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group. , 2000, The Journal of clinical endocrinology and metabolism.

[132]  D. Heron,et al.  Bilateral breast carcinoma , 2000, Cancer.

[133]  E Grunfeld,et al.  A randomized controlled trial (RCT) of routine follow-up for early stage breast cancer: A comparison of primary care versus specialist care. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[134]  A. Hordern.  Intimacy and sexuality for the woman with breast cancer. , 2000, Cancer nursing.

[135]  H. Averette,et al.  Pregnancy after breast carcinoma , 1999, Cancer.

[136]  S. Ciatto,et al.  Intensive Diagnostic Follow-up After Treatment of Primary Breast Cancer: A Randomized Trial , 1994 .

[137]  P. Ganz,et al.  Managing menopausal symptoms in breast cancer survivors: results of a randomized controlled trial. , 2000, Journal of the National Cancer Institute.

[138]  S. Rodenhuis,et al.  Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[139]  P. Ganz,et al.  Quality of life at the end of primary treatment of breast cancer: first results from the moving beyond cancer randomized trial. , 2004, Journal of the National Cancer Institute.

[140]  T. Whelan,et al.  Ipsilateral breast tumor recurrence postlumpectomy is predictive of subsequent mortality: results from a randomized trial. Investigators of the Ontario Clinical Oncology Group. , 1994, International journal of radiation oncology, biology, physics.

[141]  R. Foster,et al.  Breast self‐examination practices and breast cancer survival , 1984, Cancer.

[142]  R. Shelby,et al.  Psychological adjustment among African American breast cancer patients: one-year follow-up results of a randomized psychoeducational group intervention. , 2003, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[143]  C. Blomqvist,et al.  Ten-year follow-up of a randomized controlled trial of adjuvant clodronate treatment in node-positive breast cancer patients. , 2004, Journal of Clinical Oncology.

[144]  Jacques P. Brown,et al.  2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. , 2002, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.